Skip to main content

Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis

  • Protocol
  • First Online:
Experimental Cholestasis Research

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1981))

Abstract

Cholestasis remains a major challenge in drug-induced liver injury, and therefore warrants identification of chemical entities that may lead to cholestasis. Recent advances in cell culture methods enable 3D spheroid models to remain viable for much longer periods of time than conventional sandwich cultures of primary human hepatocytes while maintaining native tissue-like functionality, such as drug metabolism activity, receptor signaling functionality, and physiological relevance. These spheroid models enable us to study repeated exposure effects associated with chemicals and their metabolites that may ultimately progress to cholestasis and liver injury. HepaRG cells cultured as spheroids are viable for more than 4 weeks with cytochrome P450 enzymatic activities comparable to ranges observed in freshly isolated/cryopreserved suspensions of primary human hepatocytes. HepaRG spheroids form bile canalicular structures with potential application as a model to study biliary excretion processes and intrahepatic obstruction of bile flow, leading to hepatocellular damage and death. In this chapter, we describe methods to culture 3D spheroids of HepaRG cells with extensive bile canalicular structures/networks, image transport of bile acid (cholyl-lysyl-fluorescein) to the bile canaliculi, and measure cholestatic drug-induced cytotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chatterjee S, Annaert P (2018) Drug-induced cholestasis: mechanisms, models, and markers. Curr Drug Metab 19(10):808–818

    Article  CAS  Google Scholar 

  2. Watkins PB (2011) Drug safety sciences and the bottleneck in drug development. Clin Pharmacol Ther 89:788–790

    Article  CAS  Google Scholar 

  3. Stieger B, Fattinger K, Madon J et al (2000) Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118:422–430

    Article  CAS  Google Scholar 

  4. Fattinger K, Funk C, Pantze M et al (2001) The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther 69:223–231

    Article  CAS  Google Scholar 

  5. Funk C, Ponelle C, Scheuermann G, Pantze M (2001) Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 59:627–635

    Article  CAS  Google Scholar 

  6. Akashi M, Tanaka A, Takikawa H (2006) Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats. Hepatol Res 34:193–198

    Article  CAS  Google Scholar 

  7. Fouassier L, Kinnman N, Lefevre G et al (2002) Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan. J Hepatol 37:184–191

    Article  CAS  Google Scholar 

  8. Ogimura E, Sekine S, Horie T (2011) Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes. Biochem Biophys Res Commun 416:313–317

    Article  CAS  Google Scholar 

  9. Smith CM, Nolan CK, Edwards MA et al (2012) A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes. J Pharm Sci 101:3989–4002

    Article  CAS  Google Scholar 

  10. Hendriks DF, Fredriksson Puigvert L et al (2016) Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Sci Rep 6:35434

    Article  CAS  PubMed  Google Scholar 

  11. Ramaiahgari SC, den Braver MW, Herpers B et al (2014) A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Arch Toxicol 88:1083–1095

    CAS  Google Scholar 

  12. Ramaiahgari SC, Waidyanatha S, Dixon D et al (2017) From the cover: three-dimensional (3D) HepaRG spheroid model with physiologically relevant xenobiotic metabolism competence and hepatocyte functionality for liver toxicity screening. Toxicol Sci 159:124–136

    Article  CAS  PubMed  Google Scholar 

  13. EMA (21 June 2012) Guideline on the investigation of drug interactions. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/07/WC500129606.pdf. Accessed 19 Sept 2018

  14. Jonathan P, Jackson KMF, Robert L et al (2018) Cholestatic drug induced liver injury: a function of bile salt export pump inhibition and farnesoid X receptor antagonism. Appl In Vitro Toxicol 4(3):265279

    Google Scholar 

  15. Barber JA, Stahl SH, Summers C et al (2015) Quantification of drug-induced inhibition of canalicular cholyl-l-lysyl-fluorescein excretion from hepatocytes by high content cell imaging. Toxicol Sci 148:48–59

    Article  CAS  Google Scholar 

  16. Imagawa K, Takayama K, Isoyama S et al (2017) Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells. Sci Rep 7:41806

    Article  CAS  PubMed  Google Scholar 

  17. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Bradley Collins and Suramya Waidyanatha of National Toxicology Program (NTP) for assistance with chemical procurement from MRIGlobal. We thank Dr. Michael DeVito, Dr. Richard Paules, and Dr. B. Alex Merrick for their helpful comments in preparation of this chapter. Funding for this research project was provided by the National Institute of Environmental Health Sciences (NIEHS) of National Institutes of Health (NIH) (ES103318-03). NIEHS contract HHSN273201400020C provided support for the chemical procurement.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen S. Ferguson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Ramaiahgari, S.C., Ferguson, S.S. (2019). Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis. In: Vinken, M. (eds) Experimental Cholestasis Research. Methods in Molecular Biology, vol 1981. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9420-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9420-5_20

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9419-9

  • Online ISBN: 978-1-4939-9420-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics